ENLV icon

Enlivex Therapeutics

12 hedge funds and large institutions have $5.21M invested in Enlivex Therapeutics in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.

Holders
12
Holders Change
+3
Holders Change %
+33.33%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
3
Increased
3
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
VAM
1
Visium Asset Management
New York
$3.27M 844,000
KCM
2
Knoll Capital Management
Florida
$1.31M 338,110
OC
3
Oppenheimer & Co
New York
$305K 78,870 +3,475 +5%
HighTower Advisors
4
HighTower Advisors
Illinois
$140K 35,700
SIM
5
Spark Investment Management
New York
$108K 28,055 +16,726 +148%
VKH
6
Virtu KCG Holdings
New York
$40K 10,420 +10,420 New
UBS Group
7
UBS Group
Switzerland
$27K 6,938 +6,938 New
TRCT
8
Tower Research Capital (TRC)
New York
$6K 1,572 +1,569 +52,300%
LTFS
9
Ladenburg Thalmann Financial Services
Florida
$4K 1,000
Walleye Trading
10
Walleye Trading
New York
$2K 400 -100 -20%
Wells Fargo
11
Wells Fargo
California
$1K 300
Citigroup
12
Citigroup
New York
$1K 282 +282 New